Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan

Po Ren Hsueh, Chong Ren Yu, Kwen Tay Luh, Yung Ching Liu, Dine Yang, Jing Jou Yan, Tsu Lan Wu, Wen Kuei Huang, Jiunn Jong Wu, Wen Chien Ko, Hsieh Shong Leu

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

A susceptibility surveillance study of 1,274 bacterial isolates recovered from various clinical specimens from patients in intensive care units (ICUs) of five major teaching hospitals was carried out from March, 2000, to June, 2000, in Taiwan. This study demonstrated a high rate (66%) of oxacillin resistance in Staphylococcus aureus (ORSA), a high rate of nonsusceptibility to penicillin (intermediate, 50% and highly resistant, 8%), and high rates of cefotaxime nonsusceptibility for S. pneumoniae (intermediate, 29% and resistant, 4%), Enterobacter cloacae (57%), Serratia marcescens (34%), and Citrobacter freundii (60 %). High rate of ceftazidime nonsusceptibility for Pseudomonas aeruginosa (22%), and high rates of imipenem nonsusceptibility for P. aeruginosa (15%) and Acinetobacter baumannii (22%) were also found. The percentage (11.9%) of extendedspectrum β-lactamase (ESBL)-producing Escherichia coli was greater than that (11.3%) for Klebsiella pneumoniae. Rates of quinupristin-dalfopristin nonsusceptibility for S. pneumoniae (42%), Enterococcus faecium (71%), and ORSA (39%) were high, but no vancomycin-resistant enterococci were found in this study. The resistance rates of some pathogen varied by institution or type of ICUs. Surveillance for antimicrobial resistance among bacterial pathogens in hospitals, particularly in ICU settings with a preexisting higher resistance burden, is mandatory in establishing and/or modifying guidelines for empirical treatment of severe infections in ICU patients caused by these antimicrobial-resistant pathogens.

Original languageEnglish
Pages (from-to)373-382
Number of pages10
JournalMicrobial Drug Resistance
Volume7
Issue number4
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Taiwan
Intensive Care Units
Oxacillin
Pseudomonas aeruginosa
Staphylococcus aureus
Pneumonia
Citrobacter freundii
Enterobacter cloacae
Acinetobacter baumannii
Enterococcus faecium
Serratia marcescens
Ceftazidime
Cefotaxime
Imipenem
Klebsiella pneumoniae
Teaching Hospitals
Penicillins
Guidelines
Escherichia coli
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology
  • Immunology
  • Microbiology

Cite this

Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. / Hsueh, Po Ren; Yu, Chong Ren; Luh, Kwen Tay; Liu, Yung Ching; Yang, Dine; Yan, Jing Jou; Wu, Tsu Lan; Huang, Wen Kuei; Wu, Jiunn Jong; Ko, Wen Chien; Leu, Hsieh Shong.

In: Microbial Drug Resistance, Vol. 7, No. 4, 2001, p. 373-382.

Research output: Contribution to journalArticle

Hsueh, PR, Yu, CR, Luh, KT, Liu, YC, Yang, D, Yan, JJ, Wu, TL, Huang, WK, Wu, JJ, Ko, WC & Leu, HS 2001, 'Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan', Microbial Drug Resistance, vol. 7, no. 4, pp. 373-382.
Hsueh, Po Ren ; Yu, Chong Ren ; Luh, Kwen Tay ; Liu, Yung Ching ; Yang, Dine ; Yan, Jing Jou ; Wu, Tsu Lan ; Huang, Wen Kuei ; Wu, Jiunn Jong ; Ko, Wen Chien ; Leu, Hsieh Shong. / Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. In: Microbial Drug Resistance. 2001 ; Vol. 7, No. 4. pp. 373-382.
@article{e2ac1e904fd64288ac5a7c1f1e1b972b,
title = "Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan",
abstract = "A susceptibility surveillance study of 1,274 bacterial isolates recovered from various clinical specimens from patients in intensive care units (ICUs) of five major teaching hospitals was carried out from March, 2000, to June, 2000, in Taiwan. This study demonstrated a high rate (66{\%}) of oxacillin resistance in Staphylococcus aureus (ORSA), a high rate of nonsusceptibility to penicillin (intermediate, 50{\%} and highly resistant, 8{\%}), and high rates of cefotaxime nonsusceptibility for S. pneumoniae (intermediate, 29{\%} and resistant, 4{\%}), Enterobacter cloacae (57{\%}), Serratia marcescens (34{\%}), and Citrobacter freundii (60 {\%}). High rate of ceftazidime nonsusceptibility for Pseudomonas aeruginosa (22{\%}), and high rates of imipenem nonsusceptibility for P. aeruginosa (15{\%}) and Acinetobacter baumannii (22{\%}) were also found. The percentage (11.9{\%}) of extendedspectrum β-lactamase (ESBL)-producing Escherichia coli was greater than that (11.3{\%}) for Klebsiella pneumoniae. Rates of quinupristin-dalfopristin nonsusceptibility for S. pneumoniae (42{\%}), Enterococcus faecium (71{\%}), and ORSA (39{\%}) were high, but no vancomycin-resistant enterococci were found in this study. The resistance rates of some pathogen varied by institution or type of ICUs. Surveillance for antimicrobial resistance among bacterial pathogens in hospitals, particularly in ICU settings with a preexisting higher resistance burden, is mandatory in establishing and/or modifying guidelines for empirical treatment of severe infections in ICU patients caused by these antimicrobial-resistant pathogens.",
author = "Hsueh, {Po Ren} and Yu, {Chong Ren} and Luh, {Kwen Tay} and Liu, {Yung Ching} and Dine Yang and Yan, {Jing Jou} and Wu, {Tsu Lan} and Huang, {Wen Kuei} and Wu, {Jiunn Jong} and Ko, {Wen Chien} and Leu, {Hsieh Shong}",
year = "2001",
language = "English",
volume = "7",
pages = "373--382",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan

AU - Hsueh, Po Ren

AU - Yu, Chong Ren

AU - Luh, Kwen Tay

AU - Liu, Yung Ching

AU - Yang, Dine

AU - Yan, Jing Jou

AU - Wu, Tsu Lan

AU - Huang, Wen Kuei

AU - Wu, Jiunn Jong

AU - Ko, Wen Chien

AU - Leu, Hsieh Shong

PY - 2001

Y1 - 2001

N2 - A susceptibility surveillance study of 1,274 bacterial isolates recovered from various clinical specimens from patients in intensive care units (ICUs) of five major teaching hospitals was carried out from March, 2000, to June, 2000, in Taiwan. This study demonstrated a high rate (66%) of oxacillin resistance in Staphylococcus aureus (ORSA), a high rate of nonsusceptibility to penicillin (intermediate, 50% and highly resistant, 8%), and high rates of cefotaxime nonsusceptibility for S. pneumoniae (intermediate, 29% and resistant, 4%), Enterobacter cloacae (57%), Serratia marcescens (34%), and Citrobacter freundii (60 %). High rate of ceftazidime nonsusceptibility for Pseudomonas aeruginosa (22%), and high rates of imipenem nonsusceptibility for P. aeruginosa (15%) and Acinetobacter baumannii (22%) were also found. The percentage (11.9%) of extendedspectrum β-lactamase (ESBL)-producing Escherichia coli was greater than that (11.3%) for Klebsiella pneumoniae. Rates of quinupristin-dalfopristin nonsusceptibility for S. pneumoniae (42%), Enterococcus faecium (71%), and ORSA (39%) were high, but no vancomycin-resistant enterococci were found in this study. The resistance rates of some pathogen varied by institution or type of ICUs. Surveillance for antimicrobial resistance among bacterial pathogens in hospitals, particularly in ICU settings with a preexisting higher resistance burden, is mandatory in establishing and/or modifying guidelines for empirical treatment of severe infections in ICU patients caused by these antimicrobial-resistant pathogens.

AB - A susceptibility surveillance study of 1,274 bacterial isolates recovered from various clinical specimens from patients in intensive care units (ICUs) of five major teaching hospitals was carried out from March, 2000, to June, 2000, in Taiwan. This study demonstrated a high rate (66%) of oxacillin resistance in Staphylococcus aureus (ORSA), a high rate of nonsusceptibility to penicillin (intermediate, 50% and highly resistant, 8%), and high rates of cefotaxime nonsusceptibility for S. pneumoniae (intermediate, 29% and resistant, 4%), Enterobacter cloacae (57%), Serratia marcescens (34%), and Citrobacter freundii (60 %). High rate of ceftazidime nonsusceptibility for Pseudomonas aeruginosa (22%), and high rates of imipenem nonsusceptibility for P. aeruginosa (15%) and Acinetobacter baumannii (22%) were also found. The percentage (11.9%) of extendedspectrum β-lactamase (ESBL)-producing Escherichia coli was greater than that (11.3%) for Klebsiella pneumoniae. Rates of quinupristin-dalfopristin nonsusceptibility for S. pneumoniae (42%), Enterococcus faecium (71%), and ORSA (39%) were high, but no vancomycin-resistant enterococci were found in this study. The resistance rates of some pathogen varied by institution or type of ICUs. Surveillance for antimicrobial resistance among bacterial pathogens in hospitals, particularly in ICU settings with a preexisting higher resistance burden, is mandatory in establishing and/or modifying guidelines for empirical treatment of severe infections in ICU patients caused by these antimicrobial-resistant pathogens.

UR - http://www.scopus.com/inward/record.url?scp=0035698543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035698543&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 373

EP - 382

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 4

ER -